N-(2-((5-chloro-2-((4-(cyclohexylamino)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)acetamide

ID: ALA4569983

PubChem CID: 155551668

Max Phase: Preclinical

Molecular Formula: C25H29ClN6O2

Molecular Weight: 481.00

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(NC2CCCCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1

Standard InChI:  InChI=1S/C25H29ClN6O2/c1-16(33)28-20-10-6-7-11-21(20)30-24-19(26)15-27-25(32-24)31-22-13-12-18(14-23(22)34-2)29-17-8-4-3-5-9-17/h6-7,10-15,17,29H,3-5,8-9H2,1-2H3,(H,28,33)(H2,27,30,31,32)

Standard InChI Key:  BLPSZGDFXIVONQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   17.5971   -2.5836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5959   -3.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3040   -3.8121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0136   -3.4027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0108   -2.5800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3022   -2.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3038   -4.6293    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5960   -5.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5958   -5.8549    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8884   -4.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7220   -3.8102    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4291   -3.4004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1341   -3.8084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8407   -3.3993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8398   -2.5813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1265   -2.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4228   -2.5853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7125   -2.1814    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   22.5488   -3.8072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2561   -3.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9633   -3.8073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6700   -3.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6696   -2.5805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9565   -2.1729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2526   -2.5839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9630   -4.6245    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.6706   -5.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3763   -2.1702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0850   -2.5771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0840   -3.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7886   -3.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4978   -3.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4978   -2.5797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7886   -2.1684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 14 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 21 26  1  0
 26 27  1  0
 23 28  1  0
 28 29  1  0
 29 30  1  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4569983

    ---

Associated Targets(Human)

NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 481.00Molecular Weight (Monoisotopic): 480.2041AlogP: 6.33#Rotatable Bonds: 8
Polar Surface Area: 100.20Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.36CX Basic pKa: 5.74CX LogP: 5.16CX LogD: 5.15
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -1.36

References

1. Lei H, Jia F, Cao M, Wang J, Guo M, Zhu M, Zuo D, Zhai X..  (2019)  An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects.,  27  (20): [PMID:31492532] [10.1016/j.bmc.2019.115051]

Source